Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

Am J Gastroenterol. 2009 May;104(5):1170-9

View abstract

Authors

Colombel JF, Sandborn WJ, Rutgeerts P, Kamm MA, Yu AP,  Wu EQ, Pollack PF, Lomax KG, Chao J, Mulani PM